Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Impact of colchicine on mortality in patients with COVID-19. A meta-analysis.

Literature DB >> 33421583

Impact of colchicine on mortality in patients with COVID-19. A meta-analysis.

Dimitrios A Vrachatis¹, George V Giannopoulos², Sotiria G Giotaki³, Konstantinos Raisakis², Charalampos Kossyvakis², Konstantinos E Iliodromitis⁴, Bernhard Reimers⁵, Dimitrios Tousoulis³, Michael Cleman⁶, Christodoulos Stefanadis³, Alexandra Lansky⁶, Spyridon G Deftereos³.

Abstract

Entities: Chemical Disease Species

Year: 2021 PMID： 33421583 DOI： 10.1016/j.hjc.2020.11.012

Source DB: PubMed Journal: Hellenic J Cardiol ISSN： 1109-9666

× No keyword cloud information.

12 in total

1. Colchicine use in patients with COVID-19: A systematic review and meta-analysis.

Authors: Leonard Chiu; Chun-Han Lo; Max Shen; Nicholas Chiu; Rahul Aggarwal; Jihui Lee; Young-Geun Choi; Henry Lam; Elizabeth Horn Prsic; Ronald Chow; Hyun Joon Shin
Journal: PLoS One Date: 2021-12-28 Impact factor: 3.240

2. Colchicine Is Safe Though Ineffective in the Treatment of Severe COVID-19: a Randomized Clinical Trial (COLCHIVID).

Authors: Abdiel Absalón-Aguilar; Marina Rull-Gabayet; Alfredo Pérez-Fragoso; Nancy R Mejía-Domínguez; Carlos Núñez-Álvarez; David Kershenobich-Stalnikowitz; José Sifuentes-Osornio; Alfredo Ponce-de-León; Fernanda González-Lara; Eduardo Martín-Nares; Sharon Montesinos-Ramírez; Martha Ramírez-Alemón; Pamela Ramírez-Rangel; Manlio F Márquez; Juan Carlos Plata-Corona; Guillermo Juárez-Vega; Diana Gómez-Martín; Jiram Torres-Ruiz
Journal: J Gen Intern Med Date: 2021-11-09 Impact factor: 5.128

Review 3. Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine.

Authors: Dimitrios A Vrachatis; Konstantinos A Papathanasiou; Sotiria G Giotaki; Konstantinos Raisakis; Charalampos Kossyvakis; Andreas Kaoukis; Fotis Kolokathis; Gerasimos Deftereos; Konstantinos E Iliodromitis; Dimitrios Avramides; Harilaos Bogossian; Gerasimos Siasos; George Giannopoulos; Bernhard Reimers; Alexandra Lansky; Jean-Claude Tardif; Spyridon Deftereos
Journal: J Clin Med Date: 2021-10-31 Impact factor: 4.241

Review 4. Untapping host-targeting cross-protective efficacy of anticoagulants against SARS-CoV-2.

Authors: Brian F Niemeyer; Kambez H Benam
Journal: Pharmacol Ther Date: 2021-10-28 Impact factor: 13.400

Review 5. Ofeleein i mi Vlaptin-Volume II: Immunity Following Infection or mRNA Vaccination, Drug Therapies and Non-Pharmacological Management at Post-Two Years SARS-CoV-2 Pandemic.

Authors: Jannis Kountouras; Dimitra Gialamprinou; Georgios Kotronis; Apostolis Papaefthymiou; Eleftheria Economidou; Elpidoforos S Soteriades; Elisabeth Vardaka; Dimitrios Chatzopoulos; Maria Tzitiridou-Chatzopoulou; Dimitrios David Papazoglou; Michael Doulberis
Journal: Medicina (Kaunas) Date: 2022-02-17 Impact factor: 2.430

Review 6. SARS-CoV-2 and Coronavirus Disease Mitigation: Treatment Options, Vaccinations and Variants.

Authors: Almu'atasim Khamees; Jamal Bani-Issa; Mazhar Salim Al Zoubi; Taqwa Qasem; Manal Issam AbuAlArjah; Sura Ahmad Alawadin; Khayry Al-Shami; Farah E Hussein; Emad Hussein; Ibrahim H Bashayreh; Murtaza M Tambuwala; Mohannad Al-Saghir; Christopher T Cornelison
Journal: Pathogens Date: 2022-02-20

Impact of colchicine on mortality in patients with COVID-19. A meta-analysis.

1. Colchicine use in patients with COVID-19: A systematic review and meta-analysis.

2. Colchicine Is Safe Though Ineffective in the Treatment of Severe COVID-19: a Randomized Clinical Trial (COLCHIVID).

Review 3. Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine.

Review 4. Untapping host-targeting cross-protective efficacy of anticoagulants against SARS-CoV-2.

Review 5. Ofeleein i mi Vlaptin-Volume II: Immunity Following Infection or mRNA Vaccination, Drug Therapies and Non-Pharmacological Management at Post-Two Years SARS-CoV-2 Pandemic.

Review 6. SARS-CoV-2 and Coronavirus Disease Mitigation: Treatment Options, Vaccinations and Variants.

7. Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects.

8. Prognosis of patients hospitalized with a diagnosis of COVID-19 pneumonia in a tertiary hospital in Turkey.

Review 9. Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation.

Review 10. Colchicine Against SARS-CoV-2 Infection: What is the Evidence?